The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSALV.L Regulatory News (SALV)

  • There is currently no data for SALV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

16 Nov 2011 07:00

RNS Number : 1597S
3Legs Resources plc
16 November 2011
 



16 November 2011

 

3Legs Resources plc

 

Operations on Warblino LE-1H2 horizontal well

 

3Legs Resources plc (the "Company"), a company focussed on the exploration and development of unconventional oil and gas resources with a particular focus on shale gas in Europe,announces the following operational update.

 

Key points

 

·; The Warblino LE-1H2 horizontal well flowed at an initial rate of 60 to 90 mscfd of natural gas and over 1,000 bpd of fracture fluid, declining after five days of testing to approximately 18 mscfd of natural gas and 300 bpd of fracture fluid, when the well was shut-in 

·; Testing equipment has been released; further production testing proposed for spring 2012, when weather conditions are more favourable

·; The Company considers that the well could benefit from being shut in for an extended period of several months to recover from the fracture stimulation and to enable the fracture treatment fluid, potentially obstructing the flow of natural gas, to dissipate

·; Extensive coring, wireline logging, production and other data have been gathered and are being analysed in order to advance further the Company's understanding of the target formations, for reservoir assessment and for future drilling and completion designs; these analyses are expected to be completed in the first quarter of 2012

 

Baltic Basin concessions

 

Following its announcement on 26 September 2011 regarding the drilling of the Warblino LE-1 vertical pilot and LE-1H2 horizontal wells, the initial testing phase on the Warblino LE-1H2 well has been temporarily suspended. A seven stage hydraulic fracture stimulation ("frac") programme was successfully executed across the 500 metre horizontal section in the deeper lower Palaeozoic shales. This deeper zone was not included in the Competent Person's Report issued in connection with the Company's initial public offering earlier this year, as it had not been drilled in either of the Company's two (vertical) wells referred to in that report.

 

Analysis of the deeper zone indicates total organic carbon and porosity values which compare favourably to a number of US shale plays. However, the zone also presents challenges for drilling and completion (including frac design), which the Company expects to address in future operations.

 

The frac at Warblino LE-1H2 used a gelled fluid, which enabled significantly higher concentrations of sand to be delivered into the formation than can typically be achieved with a slick water solution as was used on the Lebien LE-2H well. Following the frac, the well started to unload frac fluid at over 1,000 bpd, and to flow natural gas at 60-90 mscfd. Because of the significant volumes of frac fluid, a nitrogen injection lift was initiated early to continue the flow. After five days of testing, approximately 21% of the total injected frac fluid had been recovered, and the well was continuing to produce approximately 18 mscfd of natural gas and 300 bpd of frac fluid.

 

The well was shut in after five days and the testing equipment released. The Company will continue to monitor the well over the winter period, with a view to considering further production testing in spring 2012. The Company believes that the well could benefit from being shut in for an extended period of several months to recover from the fracture stimulation and to enable the fracture fluid, potentially obstructing the flow of natural gas, to dissipate.

 

As indicated in its announcement on 26 September 2011, the Company had originally planned a longer horizontal section on the Warblino LE-1H2 well, but opted to limit the lateral length to 500 metres due to hole stability issues. The Company believes that the reduced length of the horizontal section will have had a proportional impact on the well's performance, but that data gained may enable it to overcome similar down-hole issues and to drill longer horizontal sections in future wells targeting this zone.

 

The Company is continuing its detailed analysis of data gathered from all of its wells in the Baltic Basin, including cores, logs and tests, in order to refine and update its regional geological model and potential drilling and completion designs. The Company has also acquired or agreed to acquire data from other operators in the Baltic Basin through data trades. The Company expects these analyses to be completed in the first quarter of 2012, following which it will determine a near-term exploration plan in conjunction with its venture partner ConocoPhillips.

 

Peter Clutterbuck, Chief Executive of 3Legs Resources, said:

 

"We have now concluded our 2011 drilling and testing programme for the Baltic Basin, which has achieved its objectives of completing two wells with horizontal sections and multistage fracs. We have demonstrated that shale gas can be flowed in both wells and in different horizons, and we have gathered extensive amounts of new data with which to advance further our understanding of the production potential of the reservoir. Although flow rates have been low, we expect to be able to further improve well productivity, as is often the case in other shale plays in the US at this stage of appraisal.

 

Our primary focus now is on developing improvements in hydraulic fracture and completion design which will further enhance well production rates, in addition to considering the acquisition of new 2D and 3D seismic and the drilling of a number of new wells in the near term. This is critical in order to convert this very large gas in place volume into commercial reserves. The benefits of developing a domestic energy supply from a clean fuel such as natural gas are potentially very significant, particularly in the prevailing economic climate."

 

For further information contact:

 

3Legs Resources plc

Tel:

+44 1624 811 611

Peter Clutterbuck, Chief Executive Officer

Alexander Fraser, Chief Financial Officer

Jefferies International Limited

Tel:

+44 207 029 8000

Chris Snoxall

Alex Grant

College Hill

Tel:

+44 207 457 2020

Nick Elwes

Catherine Maitland

 

 

Notes to Editors

 

3Legs Resources was established in early 2007 to focus on the exploration and development of unconventional oil and gas resources, with a particular focus on shale gas in Europe. A first mover in Poland, 3Legs Resources has acquired six licences covering approximately 1,084,000 acres (gross) in the onshore Baltic Basin, a region considered to be one of the most promising shale basins in Europe. The Company's primary targets in the Baltic Basin are the organic-rich black shales of the Lower Palaeozoic section. In addition to these assets, the Company holds onshore exploration licences over acreage near Krakow in southern Poland and in Baden-Württemberg in south-west Germany.

 

The technical information and opinions contained in this announcement have been reviewed by Peter Clutterbuck (MA Honours in Engineering, Cambridge University and former Member of the Board of the Society of Petroleum Engineers in London), Chief Executive Officer of 3Legs Resources plc, who has over 35 years of experience in the oil exploration and production industry. He has consented to the inclusion herein of such technical information and opinions.

 

www.3legsresources.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLGMMMMNKLGMZM
Date   Source Headline
9th Jan 20202:30 pmRNSCancellation of trading on AIM
20th Dec 201910:30 amRNSCancellation of AIM listing /Potential acquisition
27th Sep 201911:07 amRNSHalf-year Report - Correction
26th Sep 20192:06 pmRNSHalf-year Report
23rd Sep 20193:02 pmRNSAIM Rule 17 Notification
9th Jul 20197:30 amRNSSuspension - SalvaRx Group Plc
9th Jul 20197:30 amRNSSuspension of Trading
28th Jun 201911:26 amRNSFinal Results
31st Jan 20197:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20192:05 pmRNSSecond Price Monitoring Extn
17th Jan 20192:00 pmRNSPrice Monitoring Extension
8th Jan 20194:15 pmRNSResult of AGM and Completion of Disposal
4th Jan 20195:30 pmRNSSalvarx Group
14th Dec 20187:50 amRNSNominated Adviser Status
10th Dec 20187:00 amRNSIssue of US$1 million of Loan Notes by iOx
27th Nov 20187:00 amRNSPosting of Circular and Notice of AGM
21st Nov 20181:00 pmRNSTransaction Update
6th Nov 20187:00 amRNSDirector/PDMR Dealing
22nd Oct 20189:47 amRNSIntensity Therapeutics Update
9th Oct 20187:00 amRNSExercise of Warrants
27th Sep 20187:00 amRNSHalf-year Report
28th Aug 20185:40 pmRNSUpdate re proposed disposal and demerger
14th Aug 20187:00 amRNSProposed disposal of interest in SalvaRx Limited
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20181:17 pmRNSDelay in iOx development programme
28th Jun 20187:00 amRNSFinal Results
26th Jun 20187:00 amRNSRelated Party Loan of US$1 million
8th Mar 201812:00 pmRNSDrug Pipeline Progress and iOx Loan Note Issue
30th Oct 20174:40 pmRNSSecond Price Monitoring Extn
30th Oct 20174:35 pmRNSPrice Monitoring Extension
23rd Oct 20177:00 amRNSSubscriptions for SalvaRx Ltd Loan Facility
27th Sep 20179:00 amRNSHalf-year Report
25th Sep 20178:00 amRNSFormation of Saugatuck Therapeutics
1st Aug 20173:30 pmRNSHolding(s) in Company
1st Aug 20173:30 pmRNSHolding(s) in Company
31st Jul 20171:45 pmRNSResult of AGM
5th Jul 20173:03 pmRNSNotice of AGM
30th Jun 20178:34 amRNSFinal Results
30th May 201712:45 pmRNSIntensity Therapeutics Treats First Patient
20th Mar 20177:00 amRNSInvestment in Rift Biotherapeutics
2nd Mar 20177:00 amRNSRestructuring, Loan Conversion and Loan Facility
28th Feb 20177:00 amRNSInvestment in Nekonal
2nd Feb 20174:37 pmRNSIntensity Therapeutics
3rd Oct 20164:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20167:00 amRNSCorporate Video
13th Sep 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSDrug Pipeline Progress including Patent Grants
4th Aug 20162:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.